news Dual antibodies effective against SARS-CoV-2 variants in animal study 22 June 2021 | By Victoria Rees (Drug Target Review) In mice and hamsters, therapies made from two antibodies were found to be mostly effective against a range of SARS-CoV-2 variants.
news N439K variant of SARS-CoV-2 is resistant to some neutralising antibodies, shows study 1 February 2021 | By Hannah Balfour (Drug Target Review) The N439K mutation improves the interaction between SARS-CoV-2 Spike protein and the viral receptor ACE2 and eludes antibody-mediated immunity, say investigators.
news Antibody named S309 from SARS patient shows promise against COVID-19 20 May 2020 | By Victoria Rees (Drug Target Review) An antibody called S309, identified in a blood sample from a SARS patient, inhibits related coronaviruses, including SARS-CoV-2, researchers have found.
article COVID-19 and big pharma: what are 15 leading companies doing to develop a coronavirus vaccine? 9 April 2020 | By Victoria Rees (Drug Target Review) A new report has revealed the vaccine R&D efforts of 15 of the leading pharmaceutical companies to combat the COVID-19 coronavirus.
news New version of HIV vaccine could soon be ready for clinical trials 18 July 2019 | By Drug Target Review A promising vaccine that clears an HIV-like virus from monkeys is closer to clinical trial human testing.